In terms of DSS, a notable correlation was observed between elevated expression of POLD4 and poorer clinical outcomes in LGG, LUSC, KIRC, GBM, COAD, UVM, and PAAD (Figure 2B). This evidence concerns the gene POLD4 and glioblastoma.